Real-World data sought on prostate cancer combo therapy
NCT ID NCT06380738
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This study watches how men with a certain advanced prostate cancer (mCRPC) do when taking the drugs olaparib and abiraterone in everyday medical practice. It will track about 250 patients for up to 2 years to see how long they stay on treatment and what happens next. The goal is to learn more about real-world results, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
RECRUITINGAschaffenburg, Germany
-
Research Site
RECRUITINGAugsburg, Germany
-
Research Site
RECRUITINGBergisch Gladbach, Germany
-
Research Site
RECRUITINGBerlin, Germany
-
Research Site
RECRUITINGBonn, Germany
-
Research Site
RECRUITINGCologne, Germany
-
Research Site
RECRUITINGDresden, Germany
-
Research Site
RECRUITINGDuisburg, Germany
-
Research Site
RECRUITINGEisenach, Germany
-
Research Site
RECRUITINGEisleben Lutherstadt, Germany
-
Research Site
RECRUITINGFrankfurt, Germany
-
Research Site
RECRUITINGGreifswald, Germany
-
Research Site
RECRUITINGHalle, Germany
-
Research Site
RECRUITINGHamburg, Germany
-
Research Site
RECRUITINGHanover, Germany
-
Research Site
RECRUITINGHeidelberg, Germany
-
Research Site
RECRUITINGHeinsberg, Germany
-
Research Site
RECRUITINGHerzogenaurach, Germany
-
Research Site
RECRUITINGLeipzig, Germany
-
Research Site
RECRUITINGLübeck, Germany
-
Research Site
RECRUITINGLüneburg, Germany
-
Research Site
RECRUITINGMagdeburg, Germany
-
Research Site
RECRUITINGMarburg, Germany
-
Research Site
RECRUITINGMülheim, Germany
-
Research Site
RECRUITINGMünster, Germany
-
Research Site
RECRUITINGNeunkirchen, Germany
-
Research Site
RECRUITINGNuremberg, Germany
-
Research Site
RECRUITINGRüsselsheim am Main, Germany
-
Research Site
RECRUITINGSaalfeld, Germany
-
Research Site
RECRUITINGSpeyer, Germany
-
Research Site
RECRUITINGTrier, Germany
-
Research Site
RECRUITINGTübingen, Germany
-
Research Site
RECRUITINGWesterstede, Germany
-
Research Site
RECRUITINGWetzlar, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Chemo combo vs. radioactive drug: which tames aggressive prostate cancer?
- Can a new pill outsmart resistant prostate cancer?
- Can a radioactive 'Smart Bomb' outsmart advanced prostate cancer?
- Can an immune booster make hormone therapy work better against prostate cancer?
- Can a pill outsmart Tumors' defenses?
- Can targeted radiation tame advanced prostate cancer? a registry aims to find out